Patents by Inventor Douglas Schneider
Douglas Schneider has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20170210825Abstract: This invention relates to monospecific and multispecific antibodies that may be utilized for the diagnosis and treatment of various diseases. In addition, these antibodies may be modified by protease cleavage. Protease control or regulation may be provided by a protease site located in, for example, a linker. These protease-regulated antibodies may also be utilized for the diagnosis and treatment of various diseases.Type: ApplicationFiled: March 22, 2017Publication date: July 27, 2017Inventors: Bing LIU, David LIGHT, Zhuozhi WANG, Douglas SCHNEIDER
-
Patent number: 9624309Abstract: This invention relates to monospecific and multispecific antibodies that may be utilized for the diagnosis and treatment of various diseases. In addition, these antibodies may be modified by protease cleavage. Protease control or regulation may be provided by a protease site located in, for example, a linker. These protease-regulated antibodies may also be utilized for the diagnosis and treatment of various diseases.Type: GrantFiled: August 16, 2008Date of Patent: April 18, 2017Assignee: BAYER INTELLECTUAL PROPERTY GmbHInventors: Bing Liu, David Light, Zhuozhi Wang, Douglas Schneider
-
Patent number: 9332632Abstract: Systems and methods in accordance with embodiments of the invention implement graphene-based thermal management cores and printed wiring boards incorporating graphene-based thermal management cores. In one embodiment, a graphene-based thermal management core includes: a layer including at least one sheet of graphene; a first reinforcement layer; and a second reinforcement layer; where the layer including at least one sheet of graphene is disposed between the first reinforcement layer and the second reinforcement layer.Type: GrantFiled: August 20, 2014Date of Patent: May 3, 2016Assignee: Stablcor Technology, Inc.Inventors: Douglas Schneider, William E. Davis
-
Publication number: 20160057854Abstract: Systems and methods in accordance with embodiments of the invention implement graphene-based thermal management cores and printed wiring boards incorporating graphene-based thermal management cores. In one embodiment, a graphene-based thermal management core includes: a layer including at least one sheet of graphene; a first reinforcement layer; and a second reinforcement layer; where the layer including at least one sheet of graphene is disposed between the first reinforcement layer and the second reinforcement layer.Type: ApplicationFiled: August 20, 2014Publication date: February 25, 2016Inventors: Douglas Schneider, William E. Davis
-
Publication number: 20140317020Abstract: The invention provides a system, method, machine readable program and a graphical user interface for managing multiple accounts associated with a user. The method includes receiving a first set of information associated with identification of a user, in response to the first set of information, identifying a second set of information relating to a financial account associated with the user, the financial account being associated with a financial institution, in response to the first set of information. The method also includes identifying a third set of information relating to a health account associated with the user, the health account being associated with a healthcare institution. A fourth set of information is generated based upon the second set of information and the third set of information. The method also includes sending a signal representative of the fourth set of information. The signal may be sent to the user or a designee of the user.Type: ApplicationFiled: May 28, 2014Publication date: October 23, 2014Inventors: Linda Birbara, John P. Bench, Patrick C. Kim, Alexander M. Kleiner, Matthew P. Burkley, Nicholas Prastos, Douglas Schneider, Barbara Coluni
-
Patent number: 8775214Abstract: The invention provides a system, method, machine readable program and a graphical user interface for managing multiple accounts associated with a user. The method includes receiving a first set of information associated with identification of a user, in response to the first set of information, identifying a second set of information relating to a financial account associated with the user, the financial account being associated with a financial institution, in response to the first set of information. The method also includes identifying a third set of information relating to a health account associated with the user, the health account being associated with a healthcare institution. A fourth set of information is generated based upon the second set of information and the third set of information. The method also includes sending a signal representative of the fourth set of information. The signal may be sent to the user or a designee of the user.Type: GrantFiled: July 19, 2006Date of Patent: July 8, 2014Assignee: Thompson Reuters (Market) LLCInventors: Linda H. Birbara, John P. Bench, Patrick C. Kim, Alexander M. Kleiner, Matthew P. Burkley, Nicholas Prastos, Douglas Schneider, Barbara Coluni
-
Patent number: 8501185Abstract: Dimeric molecular complexes useful for diagnostics and therapeutics.Type: GrantFiled: May 24, 2007Date of Patent: August 6, 2013Assignee: Bayer Healthcare LLCInventors: Tara Renee Heitner Hansen, David Light, Kirk McLean, Renate Parry, Noboru Satozawa, Douglas Schneider, Marian Seto
-
Publication number: 20110229476Abstract: This invention relates to monospecific and multispecific antibodies that may be utilized for the diagnosis and treatment of various diseases. In addition, these antibodies may be modified by protease cleavage. Protease control or regulation may be provided by a protease site located in, for example, a linker. These protease-regulated antibodies may also be utilized for the diagnosis and treatment of various diseases.Type: ApplicationFiled: August 16, 2008Publication date: September 22, 2011Applicant: BAYER SCHERING PHARMA AKTIENGESELLSCHAFTInventors: Bing Liu, David Light, Zhuozhi Wang, Douglas Schneider
-
Publication number: 20110104058Abstract: Dimeric molecular complexes comprising an IgE CH4 dimerization domain useful for diagnostics and therapeutics.Type: ApplicationFiled: May 24, 2007Publication date: May 5, 2011Applicant: Bayer Schering Pharma AktiengesellschaftInventors: Tara Heitner, David Light, Kirk McLean, Renate Parry, Noboru Satozawa, Douglas Schneider, Marian Seto
-
Patent number: 7825351Abstract: A hand held electrode holder has a power on/off switch on the handle of the electrode holder and a trigger to open the clamping jaws that clamp the electrode. The holder has internal parts which operate such that the trigger cannot open the clamping jaws while the switch is in the power on position thereby reducing the possibility of an electric hazard when changing electrodes.Type: GrantFiled: November 5, 2007Date of Patent: November 2, 2010Assignee: Dazcor IP Pty LtdInventor: Darryl Douglas Schneider
-
Publication number: 20100081795Abstract: The present invention relates to antibodies, and antigen-binding antibody fragments, directed against an RG1 polypeptide. The invention further relates to methods for utilizing the antibodies, and antibody fragments, for diagnostic and therapeutic applications.Type: ApplicationFiled: September 15, 2009Publication date: April 1, 2010Applicant: Bayer Schering PharmaInventors: Richard Harkins, Deborah Parkes, Gordon Parry, Renate Parry, Douglas Schneider
-
Patent number: 7611706Abstract: The present invention relates to antibodies, and antigen-binding antibody fragments, directed against an RG1 polypeptide. The invention further relates to methods for utilizing the antibodies, and antibody fragments, for diagnostic and therapeutic applications.Type: GrantFiled: October 30, 2007Date of Patent: November 3, 2009Assignee: Bayer Schering Pharma AktiengesellschaftInventors: Richard Harkins, Deborah Parkes, Gordon Parry, Renate Parry, Douglas Schneider
-
Patent number: 7608263Abstract: The present invention relates to antibodies, and antigen-binding antibody fragments, directed against an RG1 polypeptide. The invention further relates to methods for utilizing the antibodies, and antibody fragments, for diagnostic and therapeutic applications.Type: GrantFiled: October 30, 2007Date of Patent: October 27, 2009Assignee: Bayer Schering Pharma AktiengesellschaftInventors: Richard Harkins, Deborah Parkes, Gordon Parry, Renate Parry, Douglas Schneider
-
Publication number: 20080226656Abstract: The present invention relates to antibodies, and antigen-binding antibody fragments, directed against an RG1 polypeptide. The invention further relates to methods for utilizing the antibodies, and antibody fragments, for diagnostic and therapeutic applications.Type: ApplicationFiled: October 30, 2007Publication date: September 18, 2008Applicant: Bayer Schering Pharma AktiengesellschaftInventors: Richard Harkins, Deborah Parkes, Gordon Parry, Renate Parry, Douglas Schneider
-
Publication number: 20080138899Abstract: The present invention relates to antibodies, and antigen-binding antibody fragments, directed against an RG1 polypeptide. The invention further relates to methods for utilizing the antibodies, and antibody fragments, for diagnostic and therapeutic applications.Type: ApplicationFiled: October 30, 2007Publication date: June 12, 2008Applicant: Bayer Schering Pharma AktiengesellschaftInventors: Richard Harkins, Deborah Parkes, Gordon Parry, Renate Parry, Douglas Schneider
-
Publication number: 20080128398Abstract: A hand held electrode holder has a power on/off switch on the handle of the electrode holder and a trigger to open the clamping jaws that clamp the electrode. The holder has internal parts which operate such that the trigger cannot open the clamping jaws while the switch is in the power on position thereby reducing the possibility of an electric hazard when changing electrodes.Type: ApplicationFiled: November 5, 2007Publication date: June 5, 2008Inventor: Darryl Douglas Schneider
-
Patent number: 7335748Abstract: The present invention relates to antibodies, and antigen-binding antibody fragments, directed against an RG1 polypeptide. The invention further relates to methods for utilizing the antibodies, and antibody fragments, for diagnostic and therapeutic applications.Type: GrantFiled: July 20, 2004Date of Patent: February 26, 2008Assignee: Bayer Schering Pharma AktiengesellschaftInventors: Richard Harkins, Deborah Parkes, Gordon Parry, Renate Parry, Douglas Schneider
-
Publication number: 20080033871Abstract: The invention provides a system, method, machine readable program and a graphical user interface for managing multiple accounts associated with a user. The method includes receiving a first set of information associated with identification of a user, in response to the first set of information, identifying a second set of information relating to a financial account associated with the user, the financial account being associated with a financial institution, in response to the first set of information. The method also includes identifying a third set of information relating to a health account associated with the user, the health account being associated with a healthcare institution. A fourth set of information is generated based upon the second set of information and the third set of information. The method also includes sending a signal representative of the fourth set of information. The signal may be sent to the user or a designee of the user.Type: ApplicationFiled: July 19, 2006Publication date: February 7, 2008Inventors: Linda H. Birbara, John P. Bench, Patrick C. Kim, Alexander M. Kleiner, Matthew P. Burkley, Nicholas Prastos, Douglas Schneider, Barbara Coluni
-
Patent number: 7307154Abstract: The present invention relates to novel human extracellular matrix polypeptides, designated RG1, polynucleotides encoding the polypeptides, methods for producing the polypeptides, expression vectors and genetically engineered host cells for expression of the polypeptides. The invention further relates to methods for utilizing the polynucleotides and polypeptides in research, diagnosis, and therapeutic applications.Type: GrantFiled: July 8, 2003Date of Patent: December 11, 2007Assignee: Bayer Schering Pharma AktiengesellschaftInventors: Richard Harkins, Deborah Parkes, Gordon Parry, Renate Parry, Douglas Schneider
-
Publication number: 20060266150Abstract: The invention provides a steering column assembly having a steering column jacket operable to support a steering shaft. The steering column assembly also includes a collar presenting a surface for guiding movement of the steering column jacket. The steering column assembly also includes a locking member operable to move in a first direction from an unlocked position to a locked position to increasingly urge the steering column jacket and the surface of the collar together to lock relative movement between the steering column jacket and the collar. The steering column assembly also includes a shaft operable to rotate in a first angular direction about a first axis to move the locking member in the first direction. The steering column assembly also includes a crank extending radially outwardly from the shaft. The steering column assembly also includes a lever operable to rotate in a second angular direction about a second axis spaced from the first axis.Type: ApplicationFiled: May 26, 2005Publication date: November 30, 2006Inventors: Douglas Schneider, Kurt Hilbrandt, Sam Scrivener, Thomas Spendlove